A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer
- PMID: 16997360
- DOI: 10.1016/j.ypmed.2006.07.020
A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder's opinion about ETS and lung cancer
Abstract
Ernst Wynder did not believe that environmental tobacco smoke (ETS), also known as secondhand smoke, was a cause of lung cancer because his own data did not support this. His view on the issue may have begun to change with our initial studies, carried out at the American Health Foundation, showing that metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were present in the urine of non-smokers exposed to ETS. The metabolites - 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (NNAL-Glucs) - have now emerged as leading biomarkers for the study of carcinogen exposure in non-smokers exposed to ETS. Subsequent work has consistently demonstrated elevated levels of NNAL plus NNAL-Glucs in the urine of people exposed to ETS in various field studies and throughout life. These studies strongly support the epidemiologic data demonstrating that ETS exposure causes lung cancer in non-smokers and have likely had an impact on tobacco control.
Similar articles
-
Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1109-16. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11700257
-
Uptake of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by Moldovan children.Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):7-11. doi: 10.1158/1055-9965.EPI-05-0293. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434579
-
Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.J Natl Cancer Inst. 2001 Mar 7;93(5):378-81. doi: 10.1093/jnci/93.5.378. J Natl Cancer Inst. 2001. PMID: 11238699
-
Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke.Tob Control. 2004 Mar;13 Suppl 1(Suppl 1):i48-56. doi: 10.1136/tc.2002.002816. Tob Control. 2004. PMID: 14985617 Free PMC article. Review.
-
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer.Carcinogenesis. 2002 Jun;23(6):907-22. doi: 10.1093/carcin/23.6.907. Carcinogenesis. 2002. PMID: 12082012 Review.
Cited by
-
Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.Anal Chem. 2008 Nov 1;80(21):8115-21. doi: 10.1021/ac8009005. Epub 2008 Oct 8. Anal Chem. 2008. PMID: 18841944 Free PMC article.
-
Second-hand smoke and human lung cancer.Lancet Oncol. 2008 Jul;9(7):657-66. doi: 10.1016/S1470-2045(08)70172-4. Lancet Oncol. 2008. PMID: 18598930 Free PMC article. Review.
-
The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.Biomarkers. 2011 Sep;16(6):491-7. doi: 10.3109/1354750X.2011.598565. Epub 2011 Aug 3. Biomarkers. 2011. PMID: 21812592 Free PMC article.
-
Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes.Front Immunol. 2022 Mar 21;13:846605. doi: 10.3389/fimmu.2022.846605. eCollection 2022. Front Immunol. 2022. PMID: 35386685 Free PMC article. Review.
-
Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.Nicotine Tob Res. 2013 Jan;15(1):130-8. doi: 10.1093/ntr/nts099. Epub 2012 May 9. Nicotine Tob Res. 2013. PMID: 22573723 Free PMC article.
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Medical